Series A life sciences investors
105 of 129 series a life sciences firms that report a preference say they can lead. 9 active since September.
Can leadMostly followsNot reportedRecently active
DCVCActive Oct 8
Ali Tamaseb, James Hardiman+15 on the team
The EngineActive Sep 22
Ann DeWitt, Israel Ruiz+9 on the team
Arch Venture PartnersActive Sep 28
Paul Berns, Keith Crandell+12 on the team
Foothill VenturesActive Sep 23
Jinlin Wang, Max Von Poelnitz+6 on the team
Hitachi VenturesActive Oct 15
Pete Bastien, Stefan Gabriel+19 on the team
Narya CapitalActive Sep 29
Colin Greenspon, Falon Donohue
Safar PartnersActive Oct 13
Arunas Chesonis, Nader Motamedy+6 on the team
The Longevity FundActive Sep 24
Alex Colville, Satvik Dasariraju
CompoundActive Sep 27
David Hirsch, Michael Dempsey+2 on the team
Andy J. Schwab, John D. Diekman, PhD+14 on the team
Anders Hove, Isaac Manke+2 on the team
Manuel Gonzalez, Michael Dean+8 on the team
Joel S. Marcus, Blake L. Stevens+2 on the team
Bob More, Dan Janney+1 on the team
Dave Maki, Kristen Wong
Lenny Pruss, Mike Dauber+8 on the team
Dion Madsen, Jean-Francois Pariseau+7 on the team
Ken Horne, Ari Nowacek+9 on the team
David Michael, David Seldin+9 on the team
Seth L. Harrison, Anna Batarina+1 on the team
Dan Kidle, Jan Garfinkle+6 on the team
Bruce Booth, David Grayzel+10 on the team
Christopher Male, Lauren Ingram+3 on the team
Drew Lanza, Ted Hou+1 on the team
Rob Carlson
Jamie Rutledge, Chris Cesareo+1 on the team
Murray Rode, Rafi Syed+4 on the team
Julia Moore, Lindy Fishburne+2 on the team
Daniel Gottlieb, Thomas Needham+5 on the team
Karan Wadhera, Yoni Meyer+1 on the team
George C. Petrocheilos, R. Jacob Vogelstein, Ph.D.+18 on the team
Aryeh Ganz, Jinny Choi+2 on the team
David Fallace, J.D. / M.B.A., Lou Tartaglia, Ph.D.+13 on the team
Nan Li, Zavain Dar+3 on the team
Campbell Murray, Daniel Yadegar
John H. Friedman, Kresimir Letinic+1 on the team
Chris McLeod, Rob Bettigole+1 on the team
Stephen Knight, Amber Cai+17 on the team
Aydin Senkut, James Detweiler+7 on the team
Hyung Chun, MD, Shannon Bergstedt+11 on the team
Get series a life sciences investors every Monday
Only the firms on this list that show new activity. Unsubscribe in one click.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckRelated lists
Series A investors1867Series A healthtech investors243Seed life sciences investors186Series A climate investors160Series A fintech investors158Series A enterprise software investors152Series A deep tech investors146Series A industrial investors115Series A dev tools and infra investors108Pre-seed life sciences investors95Series B life sciences investors91Series A consumer investors79
Questions
How many series a life sciences investors are there?
Mode VC tracks 167 firms on this list as of 2026-10-15. 9 have been active since September 2026.
What check size do series a life sciences investors write?
The most reported band is $3M to $10M, reported by 49 firms on this list.
Which series a life sciences investors lead rounds?
105 of 129 firms that report a preference say they can lead. Turn on "Leads rounds" to see only them.